Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mette Mejlby Hansen

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Ugeskrift for Laeger|October 9, 2014
[Successful patient-activated help call for a doctor during in-hospital stay]Mette Mejlby Hansen, Birgith Hasselkvist, Sofie Thordal, et al.
Molecular Medicine (Cambridge, Mass.)|October 25, 2023
B-vitamins, related vitamers, and metabolites in patients with quiescent inflammatory bowel disease and chronic fatigue treated with high dose oral thiaminePalle Bager, Christian Lodberg Hvas, Mette Mejlby Hansen, et al.
Gastroenterology|January 6, 2019
Fecal Microbiota Transplantation Is Superior to Fidaxomicin for Treatment of Recurrent Clostridium difficile InfectionChristian Lodberg Hvas, Simon Mark Dahl Jørgensen, Søren Peter Jørgensen, et al.
Clinical and Experimental Gastroenterology|November 22, 2021
Activation and Functional Priming of Blood Neutrophils in Non-Alcoholic Fatty Liver Disease Increases in Non-Alcoholic SteatohepatitisJohanne Sloth Lauszus, Peter Lykke Eriksen, Mette Mejlby Hansen, et al.
Therapeutic Advances in Gastroenterology|February 10, 2025
Validation methods for encapsulated faecal microbiota transplantation: a scoping reviewNina Rågård, Simon Mark Dahl Baumwall, Sara Ellegaard Paaske, et al.
Therapeutic Advances in Gastroenterology|October 18, 2024
Encapsulated donor faeces for faecal microbiota transplantation: the Glyprotect protocolMette Mejlby Hansen, Nina Rågård, Pia Winther Andreasen, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|November 8, 2022
Chronic loose stools following right-sided hemicolectomy for colon cancer and the association with bile acid malabsorption and small intestinal bacterial overgrowthHelene Mathilde Larsen, Klaus Krogh, Mette Borre, et al.
Eclinicalmedicine|July 3, 2025
Clinical management of <i>Clostridioides difficile</i> infection with faecal microbiota transplantation: a real-world cohort studySara Ellegaard Paaske, Simon Mark Dahl Baunwall, Tone Rubak, et al.
Clinical and Translational Gastroenterology|February 25, 2026
Dynamics in circulating immune cell subsets after faecal microbiota transplantation for recurrent Clostridioides difficile infectionLotte Lindgreen Eriksen, Sidsel Støy, Mette Mejlby Hansen, et al.
The Lancet. Gastroenterology & Hepatology|September 24, 2022
Faecal microbiota transplantation for first or second Clostridioides difficile infection (EarlyFMT): a randomised, double-blind, placebo-controlled trialSimon Mark Dahl Baunwall, Sara Ellegaard Andreasen, Mette Mejlby Hansen, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Ugeskrift for Laeger|October 9, 2014
[Successful patient-activated help call for a doctor during in-hospital stay]Mette Mejlby Hansen, Birgith Hasselkvist, Sofie Thordal, et al.
Molecular Medicine (Cambridge, Mass.)|October 25, 2023
B-vitamins, related vitamers, and metabolites in patients with quiescent inflammatory bowel disease and chronic fatigue treated with high dose oral thiaminePalle Bager, Christian Lodberg Hvas, Mette Mejlby Hansen, et al.
Gastroenterology|January 6, 2019
Fecal Microbiota Transplantation Is Superior to Fidaxomicin for Treatment of Recurrent Clostridium difficile InfectionChristian Lodberg Hvas, Simon Mark Dahl Jørgensen, Søren Peter Jørgensen, et al.
Clinical and Experimental Gastroenterology|November 22, 2021
Activation and Functional Priming of Blood Neutrophils in Non-Alcoholic Fatty Liver Disease Increases in Non-Alcoholic SteatohepatitisJohanne Sloth Lauszus, Peter Lykke Eriksen, Mette Mejlby Hansen, et al.
Therapeutic Advances in Gastroenterology|February 10, 2025
Validation methods for encapsulated faecal microbiota transplantation: a scoping reviewNina Rågård, Simon Mark Dahl Baumwall, Sara Ellegaard Paaske, et al.
Therapeutic Advances in Gastroenterology|October 18, 2024
Encapsulated donor faeces for faecal microbiota transplantation: the Glyprotect protocolMette Mejlby Hansen, Nina Rågård, Pia Winther Andreasen, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|November 8, 2022
Chronic loose stools following right-sided hemicolectomy for colon cancer and the association with bile acid malabsorption and small intestinal bacterial overgrowthHelene Mathilde Larsen, Klaus Krogh, Mette Borre, et al.
Eclinicalmedicine|July 3, 2025
Clinical management of <i>Clostridioides difficile</i> infection with faecal microbiota transplantation: a real-world cohort studySara Ellegaard Paaske, Simon Mark Dahl Baunwall, Tone Rubak, et al.
Clinical and Translational Gastroenterology|February 25, 2026
Dynamics in circulating immune cell subsets after faecal microbiota transplantation for recurrent Clostridioides difficile infectionLotte Lindgreen Eriksen, Sidsel Støy, Mette Mejlby Hansen, et al.
The Lancet. Gastroenterology & Hepatology|September 24, 2022
Faecal microbiota transplantation for first or second Clostridioides difficile infection (EarlyFMT): a randomised, double-blind, placebo-controlled trialSimon Mark Dahl Baunwall, Sara Ellegaard Andreasen, Mette Mejlby Hansen, et al.
Pageof 2